Clinical Trials: Search Results

Your search returned 20 results.

 
Stereotactic Body Radiotherapy for Head and Neck Tumors
Conditions:
Squamous Cell Carcinoma of the Head and Neck; Nasopharyngeal Carcinoma; Salivary Gland Cancer; Head and Neck Sarcoma; Paraganglioma of Head and Neck; Chordoma of Head and Neck; Chondrosarcoma of Head and Neck; Angiofibroma of Head and Neck

Intervention:
Radiation: stereotactic body radiotherapy; Radiation: Stereotactic body radiotherapy;
A Study of Carboplatin, Cetuximab and RAD001 in Advanced Head and Neck Cancer
Conditions:
Head and Neck Neoplasms; Cancer of the Head and Neck

Intervention:
Drug: Carboplatin; Drug: Cetuximab; Drug: RAD001;
Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma
Conditions:
Cancer of Head and Neck; Head and Neck Cancer; Neoplasms, Head and Neck; Carcinoma, Squamous Cell of Head and Neck; Squamous Cell Carcinoma of the Head and Neck; Squamous Cell Carcinoma, Head and Neck

Intervention:
Biological: MK-3475; Procedure: Surgery; Radiation: Intensity modulated radiation therapy; Radiation: Image-guided radiation therapy; Drug: Cisplatin;
The Effect on an Ionic Silver Dressing in Head and Neck Patients With Malignant Fungating Wound
Conditions:
Head and Neck Neoplasms; Head and Neck Cancer; Wounds; Ulcer

Intervention:
Other: silver-releasing dressings;
Cisplatin and Docetaxel Plus Docetaxel and Radiotherapy With Amifostine for Squamous Cell Carcinoma of the Head and Neck
Conditions:
Cancer of Head and Neck; Head Cancer; Head and Neck Cancer; Neck Cancer; Neck Neoplasms

Intervention:
Drug: Cisplatin; Drug: Docetaxel; Procedure: Radiotherapy; Drug: Amifostine;
Phase I Chemoprevention Trial With Green Tea Polyphenon E and Erlotinib in Patients With Premalignant Lesions of the Head and Neck
Conditions:
Cancer of Head and Neck; Neoplasms, Head and Neck

Intervention:
Drug: Erlotinib; Dietary Supplement: Green Tea Polyphenon E;
Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck Cancer
Conditions:
Head and Neck Cancer; Cancer of Parotid; Malignant Neoplasm of Thyroid; Melanoma; Stage IV Head and Neck Cancer

Intervention:
Drug: Cisplatin; Drug: Docetaxel; Drug: Bevacizumab; Drug: Erlotinib; Radiation: Radiotherapy;
Prognostic Evaluation of 18fmiso Pet-ct in Head and Neck Cancer
Conditions:
Cancer of Head and Neck; Head and Neck Neoplasms

Intervention:
Radiation: Positon Emission Tomography using 18F-FMISO;
Trial of Postoperative Radiation, Cisplatin, and Panitumumab in Locally Advanced Head and Neck Cancer
Conditions:
Cancer of Head; Cancer of Head and Neck; Cancer of Neck; Cancer of the Head; Cancer of the Head and Neck; Cancer of the Neck; Head and Neck Cancer; Head Cancer; Head Neoplasms; Head, Neck Neoplasms; Neck Cancer; Neck Neoplasms; Neoplasms, Head; Neoplasms, Head and Neck; Neoplasms, Neck; Neoplasms, Upper Aerodigestive Tract; UADT Neoplasms; Upper Aerodigestive Tract Neoplasms

Intervention:
Drug: Panitumumab; Drug: Cisplatin; Radiation: Radiation Therapy;
Phase III Trial Of Docetaxel Versus Docetaxel Plus ZD1839 In Head And Neck Cancer
Conditions:
Recurrent Head and Neck Cancer; Metastatic Head and Neck Cancer

Intervention:
Drug: docetaxel; Other: placebo; Drug: gefitinib;
Efficacy and Safety Study of Oxaliplatin/5-FU in Patients With Recurrent or Metastatic Head and Neck Cancer
Conditions:
Cancer of the Head and Neck; Neoplasms, Head and Neck

Intervention:
Drug: Oxaliplatin;
Reirradiation With MK-3475 in Locoregional Inoperable Recurrence or Second Primary Squamous Cell CA of the Head and Neck
Conditions:
Recurrent Head and Neck Cancer; Carcinoma, Squamous Cell of Head and Neck

Intervention:
Radiation: Reirradiation; Drug: MK-3475;
A Study to Evaluate the Safety and Efficacy of PC-A11 in Patients With Recurrent Head and Neck Squamous Cell Carcinoma
Conditions:
Recurrent Head and Neck Cancer; Carcinoma, Squamous Cell of Head and Neck

Intervention:
Drug: Amphinex induced PCI of bleomycin;
Safety and Tolerability Study of AlloVax(TM) in Patients With Metastatic or Recurrent Cancer of the Head and Neck
Conditions:
Cancer of Head and Neck; Squamous Cell Carcinoma of the Head and Neck

Intervention:
Biological: AlloVax; Biological: CRCL; Biological: AlloStim;
A Phase I Study of LJM716 in Squamous Cell Carcinoma of Head and Neck, or HER2+ Breast Cancer or Gastric Cancer
Conditions:
HER2 + Breast Cancer, HER2 + Gastric Cancer, Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma; HER2 + Breast Cancer; HER2 + Gastric Cancer; Squamous Cell Carcinoma of Head and Neck; Esophageal Squamous Cell Carcinoma

Intervention:
Drug: LJM716;
Phase 2 Study of GSK1363089 (Formerly XL880) in Adults With Squamous Cell Cancer of the Head and Neck
Conditions:
Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck; Neoplasms, Head and Neck

Intervention:
Drug: GSK1363089 (foretinib);
Cisplatin, Nab-Paclitaxel, and Cetuximab (CACTUX) in Patients With Incurable Head and Neck Squamous Cell Carcinoma
Conditions:
Head and Neck Cancer; Head and Neck Squamous Cell Carcinoma; Cancer of the Head and Neck

Intervention:
Drug: nab-paclitaxel; Drug: Cisplatin; Drug: Carboplatin; Biological: Cetuximab;
Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer
Conditions:
Recurrent Squamous Cell Carcinoma of the Head and Neck; Carcinoma, Squamous Cell; Neoplasms, Squamous Cell; Head and Neck Neoplasms; Mouth Neoplasms; Head and Neck Cancer

Intervention:
Drug: Proxinium;
Study of Proxinium Plus Best Supportive Care Versus Best Supportive Care for Patients With Advanced Head and Neck Cancer
Conditions:
Advanced Squamous Cell Carcinoma of the Head and Neck; Carcinoma, Squamous Cell; Neoplasms, Squamous Cell; Head and Neck Neoplasms; Mouth Neoplasms; Head and Neck Cancer

Intervention:
Drug: Proxinium;